429 related articles for article (PubMed ID: 28812191)
21. Improved treatment results for childhood acute myeloid leukemia in Taiwan.
Liang DC; Chan TT; Lin KH; Lin DT; Lu MY; Chen SH; Liu HC; Lin MT; Lee MT; Shu SG; Chang TK; Chen JS; Hsiao CC; Hung IJ; Hsieh YL; Chen RL; Cheng SN; Chang WH; Lee CH; Lin KS
Leukemia; 2006 Jan; 20(1):136-41. PubMed ID: 16281075
[TBL] [Abstract][Full Text] [Related]
22. Clinical characteristics and outcome of childhood de novo acute myeloid leukemia in Saudi Arabia: A multicenter SAPHOS leukemia group study.
Jastaniah W; Al Ghemlas I; Al Daama S; Ballourah W; Bayoumy M; Al-Anzi F; Al Shareef O; Alsultan A; Abrar MB; Al Sudairy R
Leuk Res; 2016 Oct; 49():66-72. PubMed ID: 27580158
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Nagler A; Labopin M; Beelen D; Ciceri F; Volin L; Shimoni A; Foá R; Milpied N; Peccatori J; Polge E; Mailhol A; Mohty M; Savani BN
Cancer; 2017 Jul; 123(14):2671-2679. PubMed ID: 28329410
[TBL] [Abstract][Full Text] [Related]
24. Outcome in 146 patients with paediatric acute myeloid leukaemia treated according to the AML99 protocol in the period 2003-06 from the Japan Association of Childhood Leukaemia Study.
Imamura T; Iwamoto S; Kanai R; Shimada A; Terui K; Osugi Y; Kobayashi R; Tawa A; Kosaka Y; Kato K; Hori H; Horibe K; Oda M; Adachi S;
Br J Haematol; 2012 Oct; 159(2):204-10. PubMed ID: 22924344
[TBL] [Abstract][Full Text] [Related]
25. Outcome of conditioning intensity in acute myeloid leukemia with monosomal karyotype in patients over 45 year-old: A study from the acute leukemia working party (ALWP) of the European group of blood and marrow transplantation (EBMT).
Poiré X; Labopin M; Cornelissen JJ; Volin L; Richard Espiga C; Veelken JH; Milpied N; Cahn JY; Yacoub-Agha I; van Imhoff GW; Michallet M; Michaux L; Nagler A; Mohty M
Am J Hematol; 2015 Aug; 90(8):719-24. PubMed ID: 26010466
[TBL] [Abstract][Full Text] [Related]
26. Increased Survival for Children With Acute Myeloid Leukemia Results From Improved Postrelapse Treatment.
Vedi A; Mitchell R; Shanmuganathan S; Oswald C; Marshall GM; Trahair T; Sivarajasingam S; Ziegler DS
J Pediatr Hematol Oncol; 2018 Oct; 40(7):541-547. PubMed ID: 29794644
[TBL] [Abstract][Full Text] [Related]
27. Treatment outcome in older patients with childhood acute myeloid leukemia.
Rubnitz JE; Pounds S; Cao X; Jenkins L; Dahl G; Bowman WP; Taub JW; Pui CH; Ribeiro RC; Campana D; Inaba H
Cancer; 2012 Dec; 118(24):6253-9. PubMed ID: 22674050
[TBL] [Abstract][Full Text] [Related]
28. Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group report.
Entz-Werle N; Suciu S; van der Werff ten Bosch J; Vilmer E; Bertrand Y; Benoit Y; Margueritte G; Plouvier E; Boutard P; Vandecruys E; Ferster A; Lutz P; Uyttebroeck A; Hoyoux C; Thyss A; Rialland X; Norton L; Pages MP; Philippe N; Otten J; Behar C;
Leukemia; 2005 Dec; 19(12):2072-81. PubMed ID: 16136166
[TBL] [Abstract][Full Text] [Related]
29. Characteristics and clinical evolution of patients with acute myeloblastic leukemia in northeast Mexico: an eight-year experience at a university hospital.
Jaime-Pérez JC; Brito-Ramirez AS; Pinzon-Uresti MA; Gutiérrez-Aguirre H; Cantú-Rodríguez OG; Herrera-Garza JL; Gomez-Almaguer D
Acta Haematol; 2014; 132(2):144-51. PubMed ID: 24556725
[TBL] [Abstract][Full Text] [Related]
30. Improved outcome in childhood acute myeloid leukemia in Singapore with the MRC AML 10 protocol.
Tan RM; Quah TC; Aung L; Liang S; Kirk RC; Yeoh AE
Pediatr Blood Cancer; 2007 Mar; 48(3):262-7. PubMed ID: 16602120
[TBL] [Abstract][Full Text] [Related]
31. Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: real-world population-based data from the Swedish Acute Leukemia Registry 1997-2006.
Juliusson G; Karlsson K; Lazarevic VLj; Wahlin A; Brune M; Antunovic P; Derolf A; Hägglund H; Karbach H; Lehmann S; Möllgård L; Stockelberg D; Hallböök H; Höglund M;
Cancer; 2011 Sep; 117(18):4238-46. PubMed ID: 21387283
[TBL] [Abstract][Full Text] [Related]
32. Outcome of HLA-matched related allogeneic hematopoietic stem cell transplantation for patients with acute leukemia in first complete remission treated in Eastern European centers. Better results in recent years.
Giebel S; Labopin M; Holowiecki J; Labar B; Komarnicki M; Koza V; Masszi T; Mistrik M; Lange A; Hellmann A; Vitek A; Pretnar J; Mayer J; Rzepecki P; Indrak K; Wiktor-Jedrzejczak W; Wojnar J; Krawczyk-Kulis M; Kyrcz-Krzemien S; Rocha V
Ann Hematol; 2009 Oct; 88(10):1005-13. PubMed ID: 19301005
[TBL] [Abstract][Full Text] [Related]
33. Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000.
Ravindranath Y; Chang M; Steuber CP; Becton D; Dahl G; Civin C; Camitta B; Carroll A; Raimondi SC; Weinstein HJ;
Leukemia; 2005 Dec; 19(12):2101-16. PubMed ID: 16136167
[TBL] [Abstract][Full Text] [Related]
34. Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.
von Neuhoff C; Reinhardt D; Sander A; Zimmermann M; Bradtke J; Betts DR; Zemanova Z; Stary J; Bourquin JP; Haas OA; Dworzak MN; Creutzig U
J Clin Oncol; 2010 Jun; 28(16):2682-9. PubMed ID: 20439630
[TBL] [Abstract][Full Text] [Related]
35. The outcomes and treatment burden of childhood acute myeloid leukaemia in Australia, 1997-2008: A report from the Australian Paediatric Cancer Registry.
Foresto SA; Youlden DR; Baade PD; Hallahan AR; Aitken JF; Moore AS
Pediatr Blood Cancer; 2015 Sep; 62(9):1664-6. PubMed ID: 25855531
[TBL] [Abstract][Full Text] [Related]
36. Childhood acute myeloid leukemia: an Indian perspective.
Kulkarni KP; Marwaha RK
Pediatr Hematol Oncol; 2011 May; 28(4):257-68. PubMed ID: 21214409
[TBL] [Abstract][Full Text] [Related]
37. Cure rates of childhood acute lymphoblastic leukemia in Lithuania and the benefit of joining international treatment protocol.
Vaitkevičienė G; Matuzevičienė R; Stoškus M; Žvirblis T; Ragelienė L; Schmiegelow K
Medicina (Kaunas); 2014; 50(1):28-36. PubMed ID: 25060202
[TBL] [Abstract][Full Text] [Related]
38. Treatment outcomes of pediatrics acute myeloid leukemia (AML) and associated factors in the country's tertiary referral hospital, Ethiopia.
Mamo W; Moges A; Yesuf SA; Mohamedsaid A; Arega G
BMC Cancer; 2024 May; 24(1):640. PubMed ID: 38789952
[TBL] [Abstract][Full Text] [Related]
39. Pediatric therapy-related myelodysplastic syndrome/acute myeloid leukemia: the MD Anderson Cancer Center experience.
Aguilera DG; Vaklavas C; Tsimberidou AM; Wen S; Medeiros LJ; Corey SJ
J Pediatr Hematol Oncol; 2009 Nov; 31(11):803-11. PubMed ID: 19801947
[TBL] [Abstract][Full Text] [Related]
40. Expanded activated autologous lymphocyte infusions improve outcomes of low- and intermediate-risk childhood acute myeloid leukemia with low level of minimal residual disease.
Zhang LP; Lu AD; Wu J; Jia YP; Zuo YX; Zhang YH; Zhao YH; Shang W; Xie DF; Li YC; Sun Z; Ma SQ
Cancer Lett; 2020 Nov; 493():128-132. PubMed ID: 32829005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
